Promoting Biomedical Research and Public Health for Patients Act

[AI summary unavailable — showing source text] Promoting Biomedical Research and Public Health for Patients Act This bill amends the Public Health Service Act to revise reporting requirements for the National Institutes of Health (NIH) and certain national research institutes. The Department of Health and Human Services (HHS) and the NIH must review and revise policies, including policies on conflicts of interest and laboratory animals, to reduce the administrative burden on researchers while maintaining the integrity and credibility of research findings. The Office of Management and Budget must establish the Research Policy Board to make recommendations to minimize the administrative burden of federal research policies while maintaining responsible oversight. Contractors making substances and living organisms available for research on behalf of HHS may collect payments on behalf of HHS for incurred costs. HHS must revise the Vaccine Injury Table to include information on vaccines recommended by the Centers for Disease Control and Prevention for pregnant women. The bill revises provisions regarding the clinical trial registry data bank to permit earlier publication of certain data and to categorize clinical trials for combinati…